l carnitine tmao koeth 2013 nature medicine Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in
Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis Frontiers Impacts of intestinal microbiota metabolite trimethylamine N oxide on cardiovascular disease: a bibliometric analysis Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




